DISIPAL Drug Patent Profile
✉ Email this page to a colleague
When do Disipal patents expire, and what generic alternatives are available?
Disipal is a drug marketed by 3M and is included in one NDA.
The generic ingredient in DISIPAL is orphenadrine hydrochloride. There are nine drug master file entries for this compound. Additional details are available on the orphenadrine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DISIPAL?
- What are the global sales for DISIPAL?
- What is Average Wholesale Price for DISIPAL?
Summary for DISIPAL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 96 |
| Patent Applications: | 3,425 |
| DailyMed Link: | DISIPAL at DailyMed |
US Patents and Regulatory Information for DISIPAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3m | DISIPAL | orphenadrine hydrochloride | TABLET;ORAL | 010653-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
